Abiopharma

🔍 Todisco Joseph (Director)

Company: CorMedix Inc. (CRMD)

Report Date: 2026-01-12

Detailed Transactions and Holdings:

• Sold 17,417 shares of Common Stock at $7.15 per share (Direct)
  Date: 2026-01-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 492,079.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 29,585 shares of Common Stock at $3.38 per share (Direct)
  Date: 2026-01-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 521,664.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 22,665 shares of Common Stock at $6.78 per share (Direct)
  Date: 2026-01-17 | Code: F | equity_swap_involved: 0 | shares_owned_after: 498,999.00 | transaction_form_type: 4
• Sold 29,585 shares of Stock Option (Right to Buy Common Stock) at $3.38 per share (Derivative)
  Date: 2026-01-16 | Code: M | Expires: 2032-05-09 | equity_swap_involved: 0 | shares_owned_after: 411,245.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: This transaction is being reported late due to an inadvertent administrative error.
• F2: The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.
• F3: These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.
• REMARKS: Exhibit 24.1 - Power of Attorney